Rite Aid (RAD)

Add a New Bears Reason Company: Rite Aid (RAD) Current price: Headline: (100 character max) Analysis: Cancel 75% agree 54 votes   Rite Aid explores refinancing options after quarterly losses Top Contributor: Rashad Badr | Created when NYSE:RAD was $0.90 | Edit | History Rite Aid posted larger-than-expected quarterly losses for the fourth quarter. Rite Aid, which has posted losses for seven consecutive quarters, forecast another loss for FY2009. Rite Aid has in turn announced plans to deal with debt and inefficiency. (100 character max) Cancel 54% agree 48 votes   Walmart's $4 prescription program is expanding Top Contributor: Carl McCabe | Created when NYSE:RAD was $2.39 | Edit | History Walmart's pharmacy is selling deeply discounted generics. This could attract customers away from Rite Aid. (100 character max) Cancel 50% agree 2 votes   Rite Aid discontinues $4.00 prescriptions Created when NYSE:RAD was $0.89 | Edit | History Acting again on their financial woes, Rite Aid has opted to discontinue their $4.00 prescriptions, leaving cash customers to transfer to Wal-Mart etc. who offer this discounted program. (100 character max) Cancel 33% agree 3 votes   Moody's Credit Rating Agency Highlights Rite Aid's Debt Problems Top Contributor: Rashad Badr | Created when NYSE:RAD was $0.27 | Edit | History Moody's Credit Rating Agency published a report listing companies with debt difficulties. Rite Aid was included on this list and is likely to default on its debt, according to the agency. (100 character max) Cancel 0% agree 1 votes   rad Created when NYSE:RAD was $0.30 | Edit | History Rite aid matches competitors prices. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.